Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)

NCT01774630

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • CHU Angers Angers, France
  • Institut Bergonié Bordeaux, France
  • Centre Hospitalier de Versailles - Hôpital André Mignot - Service de Médecine B Le Chesnay, France
  • CHU de Nice, Service Hématologie Clinique Nice, France
View Trial Details
Completed

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

NCT02493530

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Mays Cancer Center at University of Texas Health San Antonio San Antonio, Texas, United States
View Trial Details
Completed

A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

NCT05558696

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • BRCR Global ( Site 0120) Plantation, Florida, United States
  • Hematology Oncology of the North Shore ( Site 0104) Skokie, Illinois, United States
  • University of Michigan Comprehensive Cancer Center ( Site 0008) Ann Arbor, Michigan, United States
  • Comprehensive Cancer Centers of Nevada - Peak ( Site 0118) Las Vegas, Nevada, United States
View all 17 locations
View Trial Details
Completed

Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)

NCT04254978

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Local Institution Jacksonville, Florida, United States
  • Local Institution Ann Arbor, Michigan, United States
  • Local Institution New York, United States
  • Local Institution Durham, North Carolina, United States
View all 26 locations
View Trial Details
Completed

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.

NCT03578367

Conditions
Bone Marrow Diseases, CML, Chronic Disease, +13 more
Locations
  • Georgia Regents University Augusta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Montreal, Quebec, Canada
View all 30 locations
View Trial Details
Completed

Fedratinib in Combination With Nivolumab

NCT05393674

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
  • University Medicine Greifswald Greifswald, Germany
  • Universitätsklinikum Halle (Saale) Halle, Germany
  • Medizinische Hochschule Hanover, Germany
View Trial Details
Completed

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

NCT04472598

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Highlands Oncology Group, PA /ID# 221824 Springdale, Arkansas, United States
  • Providence - St. Jude Medical Center /ID# 241646 Fullerton, California, United States
  • Moores Cancer Center at UC San Diego /ID# 218012 La Jolla, California, United States
  • Rocky Mountain Cancer Centers - Littleton /ID# 222562 Littleton, Colorado, United States
View all 194 locations
View Trial Details

Related conditions